标题
Basis for Immunotherapy for Treatment of Meningiomas
作者
关键词
-
出版物
Frontiers in Neurology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-08-28
DOI
10.3389/fneur.2020.00945
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A Rapid Robust Method for Subgrouping Non-NF2 Meningiomas According to Genotype and Detection of Lower Levels of M2 Macrophages in AKT1 E17K Mutated Tumours
- (2020) Claire L. Adams et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The prognostic role of Ki-67/MIB-1 in meningioma
- (2020) Ning Liu et al. MEDICINE
- Rapid development of an atypical meningioma during Nivolumab therapy for metastatic renal cell carcinoma
- (2020) N. Abele et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
- (2019) Timothy F. Cloughesy et al. NATURE MEDICINE
- Systemic and local immunosuppression in patients with high-grade meningiomas
- (2019) Yuping D. Li et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Multimodality Therapy of Patients with Refractory Meningiomas
- (2019) Haroon Ahmad et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Predictive Biomarkers for Checkpoint Inhibitor-Based Immunotherapy: The Galectin-3 Signature in NSCLCs
- (2019) Carlo Capalbo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Trabectedin for recurrent WHO grade II or III meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG).
- (2019) Matthias Preusser et al. JOURNAL OF CLINICAL ONCOLOGY
- Non-NF2 mutations have a key effect on inhibitory immune checkpoints and tumor pathogenesis in skull base meningiomas
- (2019) Shuyu Hao et al. JOURNAL OF NEURO-ONCOLOGY
- CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016
- (2019) Quinn T Ostrom et al. NEURO-ONCOLOGY
- Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumors
- (2019) Akash J. Patel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expression and Clinical Significance of Immune Checkpoint Regulator B7-H3 (CD276) in Human Meningioma
- (2019) Jiaojiao Deng et al. World Neurosurgery
- Current Role of Radiation Therapy in the Management of Malignant Central Nervous System Tumors
- (2019) Ahsan Farooqi et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence
- (2018) Leah M. Katz et al. ACTA NEUROPATHOLOGICA
- Programmed death ligand 1 expression and tumor infiltrating lymphocytes in neurofibromatosis type 1 and 2 associated tumors
- (2018) Shiyang Wang et al. JOURNAL OF NEURO-ONCOLOGY
- Integrated genomic analyses of de novo pathways underlying atypical meningiomas
- (2018) Akdes Serin Harmancı et al. Nature Communications
- NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives
- (2018) Remy Thomas et al. Frontiers in Immunology
- Immunosuppressive activity of tumor-infiltrating myeloid cells in patients with meningioma
- (2018) Laura Pinton et al. OncoImmunology
- OUP accepted manuscript
- (2018) NEURO-ONCOLOGY
- Identification of PD-L2, B7-H3 and CTLA-4 immune checkpoint proteins in genetic subtypes of meningioma
- (2018) Dustin Proctor et al. OncoImmunology
- Systemic therapy for relapsed/refractory meningioma: Is there potential for antiangiogenic agents?
- (2018) Constantin A Dasanu et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- New molecular targets in meningiomas
- (2018) Vyshak Alva Venur et al. CURRENT OPINION IN NEUROLOGY
- Immunotherapy revolutionises non-small-cell lung cancer therapy: Results, perspectives and new challenges
- (2017) Etienne Giroux Leprieur et al. EUROPEAN JOURNAL OF CANCER
- Innate immunity may play a role in growth and relapse of chordoid meningioma
- (2017) Ivan Presta et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Regression of intracranial meningioma following treatment with nivolumab: Case report and review of the literature
- (2017) Efrat Gelerstein et al. JOURNAL OF CLINICAL NEUROSCIENCE
- The use of immunotherapy in the treatment of melanoma
- (2017) Tala Achkar et al. Journal of Hematology & Oncology
- Necrosis is a consistent factor to recurrence of meningiomas: should it be a stand-alone grading criterion for grade II meningioma?
- (2017) Pedro Góes et al. JOURNAL OF NEURO-ONCOLOGY
- Atypical and anaplastic meningioma: outcomes in a population based study
- (2017) T. Garzon-Muvdi et al. JOURNAL OF NEURO-ONCOLOGY
- Meningioma recurrence rates following treatment: a systematic analysis
- (2017) Victor Lam Shin Cheung et al. JOURNAL OF NEURO-ONCOLOGY
- DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis
- (2017) Felix Sahm et al. LANCET ONCOLOGY
- Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy
- (2017) Tiffany R. Hodges et al. NEURO-ONCOLOGY
- Recurrent glioma clinical trial, CheckMate-143: the game is not over yet
- (2017) Anna C. Filley et al. Oncotarget
- PD1 signal transduction pathways in T cells
- (2017) Hugo Arasanz et al. Oncotarget
- Checkpoint inhibition: new treatment options in urologic cancer
- (2017) Daan Joost De Maeseneer et al. ACTA CLINICA BELGICA
- Genomic landscape of advanced basal cell carcinoma: Implications for precision treatment with targeted and immune therapies
- (2017) Aaron M. Goodman et al. OncoImmunology
- Immunotherapy Progress in Mismatch Repair–Deficient Colorectal Cancer and Future Therapeutic Challenges
- (2016) James T. Link et al. CANCER JOURNAL
- Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
- (2016) Jonathan M. Pitt et al. IMMUNITY
- Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma
- (2016) Seunggu J. Han et al. JOURNAL OF NEURO-ONCOLOGY
- Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes
- (2016) Ariel E. Marciscano et al. JOURNAL OF NEUROSURGERY
- The Simpson grading revisited: aggressive surgery and its place in modern meningioma management
- (2016) Konstantinos Gousias et al. JOURNAL OF NEUROSURGERY
- Predictive biomarkers for checkpoint inhibitor-based immunotherapy
- (2016) Geoffrey T Gibney et al. LANCET ONCOLOGY
- The role and regulatory mechanism of IL-1β on the methylation of the NF2 gene in benign meningiomas and leptomeninges
- (2016) Baofeng Wang et al. MOLECULAR CARCINOGENESIS
- Spinal meningiomas: clinicoradiological factors predicting recurrence and functional outcome
- (2016) Tanmoy K. Maiti et al. Neurosurgical Focus
- Advances in targeted and immunobased therapies for colorectal cancer in the genomic era
- (2016) Heng Seow et al. OncoTargets and Therapy
- Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review
- (2015) Leland Rogers et al. JOURNAL OF NEUROSURGERY
- Descriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United States
- (2015) Varun R. Kshettry et al. NEURO-ONCOLOGY
- An evidence-based treatment algorithm for the management of WHO Grade II and III meningiomas
- (2015) Sam Q. Sun et al. Neurosurgical Focus
- Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma
- (2015) Ziming Du et al. Oncotarget
- Tumor-intrinsic oncogene pathways mediating immune avoidance
- (2015) Stefani Spranger et al. OncoImmunology
- Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma
- (2014) Adriana Olar et al. BRAIN PATHOLOGY
- Biochemical Signaling of PD-1 on T Cells and Its Functional Implications
- (2014) Vassiliki A. Boussiotis et al. CANCER JOURNAL
- A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomas
- (2014) Jeffrey J. Raizer et al. JOURNAL OF NEURO-ONCOLOGY
- Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review
- (2014) T. Kaley et al. NEURO-ONCOLOGY
- Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma
- (2014) Thomas J. Kaley et al. NEURO-ONCOLOGY
- Management of Atypical Cranial Meningiomas, Part 2
- (2014) Sam Q. Sun et al. NEUROSURGERY
- The Continuum of Cancer Immunosurveillance: Prognostic, Predictive, and Mechanistic Signatures
- (2013) Jérôme Galon et al. IMMUNITY
- Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations
- (2013) Priscilla K Brastianos et al. NATURE GENETICS
- The immune cell infiltrate populating meningiomas is composed of mature, antigen-experienced T and B cells
- (2013) L. Fang et al. NEURO-ONCOLOGY
- Association between Inflammatory Infiltrates and Isolated Monosomy 22/del(22q) in Meningiomas
- (2013) Patrícia Henriques Domingues et al. PLoS One
- Genomic Analysis of Non-NF2 Meningiomas Reveals Mutations in TRAF7, KLF4, AKT1, and SMO
- (2013) V. E. Clark et al. SCIENCE
- NY-ESO-1 Expression in Meningioma Suggests a Rationale for New Immunotherapeutic Approaches
- (2013) G. S. Baia et al. Cancer Immunology Research
- Radiation Treatment for WHO Grade II and III Meningiomas
- (2013) Brian P. Walcott et al. Frontiers in Oncology
- Immunophenotypic Identification and Characterization of Tumor Cells and Infiltrating Cell Populations in Meningiomas
- (2012) Patrícia H. Domingues et al. AMERICAN JOURNAL OF PATHOLOGY
- The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis
- (2011) M J M Gooden et al. BRITISH JOURNAL OF CANCER
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningioma
- (2011) David A. Reardon et al. JOURNAL OF NEURO-ONCOLOGY
- Epidemiology and etiology of meningioma
- (2010) Joseph Wiemels et al. JOURNAL OF NEURO-ONCOLOGY
- Medical therapies for meningiomas
- (2010) Patrick Y. Wen et al. JOURNAL OF NEURO-ONCOLOGY
- Outcome and survival following primary and repeat surgery for World Health Organization Grade III meningiomas
- (2010) Michael E. Sughrue et al. JOURNAL OF NEUROSURGERY
- Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma
- (2009) Andrew D. Norden et al. JOURNAL OF NEURO-ONCOLOGY
- Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08)
- (2009) Patrick Y. Wen et al. NEURO-ONCOLOGY
- LONG-TERM RECURRENCE RATES OF ATYPICAL MENINGIOMAS AFTER GROSS TOTAL RESECTION WITH OR WITHOUT POSTOPERATIVE ADJUVANT RADIATION
- (2009) Manish K. Aghi et al. NEUROSURGERY
- FOXP3 expression accurately defines the population of intratumoral regulatory T cells that selectively accumulate in metastatic melanoma lesions
- (2008) M. Ahmadzadeh et al. BLOOD
- Meningioma
- (2008) Christine Marosi et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The microglial/macrophagic response at the tumour-brain border of invasive meningiomas
- (2008) S. Grund et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started